CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net sales	$ 2,218.7	$ 1,516.4	$ 3,991.0	$ 2,947.1
Reimbursement Revenue	50.4	0.0	71.3	0.0
Revenues	2,269.1	1,516.4	4,062.3	2,947.1
Cost of sales	1,444.1	947.8	2,593.2	1,861.7
Cost of Reimbursable Expense	50.4	0.0	71.3	0.0
Cost of Revenue	1,494.5	947.8	2,664.5	1,861.7
Gross profit	774.6	568.6	1,397.8	1,085.4
Selling, general and administrative expenses	392.4	297.9	832.8	582.8
Amortization of intangibles and other assets	46.6	22.0	79.0	43.0
Restructuring and other special charges	14.3	2.0	33.6	9.6
Operating income	321.3	246.7	452.4	450.0
Other income (expenses):
Interest expense	(57.9)	(25.8)	(162.2)	(51.5)
Equity method income, net	2.9	3.7	5.6	6.7
Investment income	0.3	0.4	0.9	0.6
Other, net	(2.3)	7.5	(1.2)	14.4
Earnings before income taxes	264.3	232.5	295.5	420.2
Provision for income taxes	95.6	90.8	125.2	165.0
Net earnings	168.7	141.7	170.3	255.2
Less: Net earnings attributable to the noncontrolling interest	(0.3)	(0.4)	(0.6)	(0.8)
Net earnings attributable to Laboratory Corporation of America Holdings	$ 168.4	$ 141.3	$ 169.7	$ 254.4
Basic earnings per common share (in dollars per share)	$ 1.67	$ 1.67	$ 1.76	$ 3.00
Diluted earnings per common share (in dollars per share)	$ 1.64	$ 1.64	$ 1.73	$ 2.94
Covance [Member]
Revenues	$ 620.8		$ 888.0
Other income (expenses):
Net earnings attributable to Laboratory Corporation of America Holdings	$ 35.8		$ 20.4